Nexis Vision
Latest round
- Series C
Last raised
- Sep 2013
Total raised
- $28M
Investors
- 3
About Nexis Vision
Nexis Vision, Inc.Founded in 2007 and headquartered in Menlo Park, US, Nexis Vision, Inc. develops sophisticated healthcare imaging technologies.Nexis Vision, Inc. specializes in advanced imaging and diagnostic tools tailored for the healthcare sector.The company generates revenue through its innovative imaging technology solutions, serving healthcare providers who require advanced diagnostic tools.Nexis Vision, Inc.75 mn to enhance its product development efforts, focusing on launching new imaging technologies aimed at expanding their market reach in North America and Europe by 2025. Additionally, the company is exploring partnerships to facilitate entry into emerging markets in Asia, targeting the establishment of operations by the end of 2024.
Who invested in Nexis Vision
3 investors across 3 rounds
See all investors in Nexis Vision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nexis Vision
Who invested in Nexis Vision?
Nexis Vision has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nexis Vision raised?
Nexis Vision has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nexis Vision last raise money?
Nexis Vision's most recent round on record is a Series C, in Sep 2013.
What does Nexis Vision do?
Nexis Vision is a biotechnology company.
Where is Nexis Vision headquartered?
Nexis Vision is headquartered in Menlo Park, US.
Which VCs invest in companies like Nexis Vision?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nexis Vision's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Nexis Vision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.